Literature DB >> 18667595

Determination of human rotavirus VP6 genogroups I and II by reverse transcription-PCR.

Yi-Pei Lin1, Chuan-Liang Kao, Sui-Yuan Chang, Koki Taniguchi, Pei-Yung Hung, Hsueh-Ching Lin, Li-Min Huang, Hsueh-Hung Huang, Jyh-Yuan Yang, Chun-Nan Lee.   

Abstract

Based on nucleotide sequence and phylogenetic analysis of the partial VP6 genes, group A rotaviruses can be mainly differentiated into two genogroups. In this study, a method employing reverse transcription-PCR (RT-PCR) and degenerate primers was established to assign the VP6 genogroup. VP6 genogroup I and genogroup II could be determined according to the sizes of the amplicons: 380 and 780 bp, respectively. The VP6 genogroup of human reference strains of G1 to G4 and G9 types and RotaTeq vaccine strains could be properly assigned by RT-PCR. Eighty rotavirus-positive fecal samples were subjected to enzyme-linked immunosorbent assay (ELISA), RT-PCR, and sequencing of the partial VP6 gene for subgroup and genogroup determination. The results correlated well among these three methods, except for seven samples whose subgroups could not be determined by ELISA. VP6 genogroups of another 150 rotavirus strains recovered between 1981 and 2005 were determined by RT-PCR and sequencing, and the same results were obtained by these two methods. Furthermore, an additional 524 rotavirus-positive fecal samples were tested by RT-PCR, and the VP6 genogroups could be easily determined. The RT-PCR assay developed here provided a reliable and convenient method for assigning the VP6 genogroups of human rotaviruses with a wide range of genetic variation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667595      PMCID: PMC2566130          DOI: 10.1128/JCM.00432-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Receptor activity of rotavirus nonstructural glycoprotein NS28.

Authors:  K S Au; W K Chan; J W Burns; M K Estes
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

2.  Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens.

Authors:  V Gouvea; R I Glass; P Woods; K Taniguchi; H F Clark; B Forrester; Z Y Fang
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

Review 3.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

4.  Comparative sequence analysis of the genomic segment 6 of four rotaviruses each with a different subgroup specificity.

Authors:  M Gorziglia; Y Hoshino; K Nishikawa; W L Maloy; R W Jones; A Z Kapikian; R M Chanock
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

Review 5.  Molecular determinant of rotavirus neutralization and protection.

Authors:  S M Matsui; E R Mackow; H B Greenberg
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

6.  Detection of human rotaviruses which do not react with subgroup I- and II-specific monoclonal antibodies.

Authors:  L Svensson; L Grahnquist; C A Pettersson; M Grandien; G Stintzing; H B Greenberg
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

7.  Production of subgroup-specific monoclonal antibodies against human rotaviruses and their application to an enzyme-linked immunosorbent assay for subgroup determination.

Authors:  K Taniguchi; T Urasawa; S Urasawa; T Yasuhara
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

8.  Isolation, propagation, and characterization of a second equine rotavirus serotype.

Authors:  Y Hoshino; R G Wyatt; H B Greenberg; A R Kalica; J Flores; A Z Kapikian
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Identification of group A rotavirus gene 4 types by polymerase chain reaction.

Authors:  J R Gentsch; R I Glass; P Woods; V Gouvea; M Gorziglia; J Flores; B K Das; M K Bhan
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

10.  The rotavirus nonstructural glycoprotein NSP4 mobilizes Ca2+ from the endoplasmic reticulum.

Authors:  P Tian; M K Estes; Y Hu; J M Ball; C Q Zeng; W P Schilling
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  5 in total

1.  Rotavirus genotype distribution during the pre-vaccine period in Bolivia: 2007-2008.

Authors:  Rosario Rivera; Kristen Forney; Maria René Castro; Paulina A Rebolledo; Nataniel Mamani; Maritza Patzi; Percy Halkyer; Juan S Leon; Volga Iñiguez
Journal:  Int J Infect Dis       Date:  2013-05-17       Impact factor: 3.623

Review 2.  Current status of rotavirus vaccines.

Authors:  Ching-Min Wang; Shou-Chien Chen; Kow-Tong Chen
Journal:  World J Pediatr       Date:  2015-10-11       Impact factor: 2.764

3.  Genetic diversity of rotavirus genome segment 6 (encoding VP6) in Pretoria, South Africa.

Authors:  Martin M Nyaga; Mathew D Esona; Khuzwayo C Jere; Ina Peenze; Mapaseka L Seheri; M Jeffrey Mphahlele
Journal:  Springerplus       Date:  2014-04-05

4.  Disease caused by rotavirus infection.

Authors:  Che-Liang Lin; Shou-Chien Chen; Shyun-Yeu Liu; Kow-Tong Chen
Journal:  Open Virol J       Date:  2014-12-11

Review 5.  Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials.

Authors:  Zabihollah Shoja; Somayeh Jalilvand; Tayebeh Latifi; Farzin Roohvand
Journal:  Arch Virol       Date:  2022-03-15       Impact factor: 2.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.